Quick Answer
Cingulate Inc. reported R&D Expense of $9.77 million for fiscal year 2025.
Cingulate Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.77M | +3.5% |
| 2024 | $9.45M | -39.0% |
| 2023 | $15.49M | +72.2% |
| 2022 | $9.00M | +7.0% |
| 2021 | $8.41M | +65.1% |
| 2020 | $5.09M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.85M | +99.4% | +5.5% |
| June 30, 2025 | $2.70M | +43.6% | +21.5% |
| March 31, 2025 | $2.22M | +23.0% | +55.6% |
| September 30, 2024 | $1.43M | -63.6% | -24.1% |
| June 30, 2024 | $1.88M | -57.8% | +4.1% |
| March 31, 2024 | $1.81M | -15.1% | -53.9% |
| September 30, 2023 | $3.92M | +84.8% | -11.9% |
| June 30, 2023 | $4.46M | +104.6% | +109.3% |
- Cingulate Inc. showed an increase of +3.5% in R&D Expense compared to the prior fiscal year.
- Over the 2020–2025 period, Cingulate Inc.’s r&d expense has grown by 91.9% (from $5.09 million to $9.77 million).
- The most recent figure is from Cingulate Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 18, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: